Close

Needham & Company Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); Favorably Inclined Based on NPS558 Trial Results Sep 22, 2011 02:29PM
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Positive After Conference Call on STEPS May 3, 2011 11:32AM
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); 4Q10 Review; Attractive Valuation Post-Phase 3 Gattex Results Feb 16, 2011 08:30AM
Notable 52-Week Highs and Lows of the Day 01/31: XOM, DEPO, NPSP, PLL High; BGP, AIB Low Jan 31, 2011 02:45PM
Needham & Company Ups Price Target NPS Pharmaceuticals (NPSP) to $15 Jan 31, 2011 10:57AM


Aug 5, 2010 08:10AM Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); GATTEX STEPS Phase 3 Trial Enrollment Completed
Apr 16, 2010 09:15AM NPS Pharma (NPSP) Prices 9M Common Offering at $5.50/Share
Apr 15, 2010 05:39PM After-Hours Movers 4/15: LGF, BSX, SIMO Higher; NPSP, GOOG, AMD, HNSN Lower
Apr 15, 2010 04:05PM NPS Pharma (NPSP) to Offer 7.5M in Public Offering
Apr 7, 2010 10:46AM Notable Analyst Rating Changes 04/07: NOK, KEY, AIB, IRE, DRI Upgraded; LVS, NFLX, SNH Downgraded
Apr 7, 2010 10:32AM NPS Pharmaceuticals Shares (NPSP) Jump As Needham Analyst Says Time For Revisit
Apr 7, 2010 06:56AM Needham & Company Initiates Coverage on NPS Pharmaceuticals (NPSP) with a Buy; Underappreciated Late-Stage Pipeline